Structured treatment interruption in patients with alveolar echinococcosis.
about
In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosusEchinococcus metacestode: in search of viability markersProposal of a computed tomography classification for hepatic alveolar echinococcosisMultimodality imaging in diagnosis and management of alveolar echinococcosis: an update.Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification-ultrasound.Treatment of echinococcosis: albendazole and mebendazole--what else?Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones.Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomographyIn vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivativesInnovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options.Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.PET/CT imaging in infectious conditions.Hydatid cyst of spleen: a diagnostic challenge.Two-stage hepatectomy for multiple giant alveolar echinococcosis.In vitro effects of some herbs used in Egyptian traditional medicine on viability of protoscolices of hydatid cysts.Living donor liver transplantation for Echinococcus Alveolaris: single-center experience.Evaluation of the Metabolic Activity of Echinococcus multilocularis in Rodents Using Positron Emission Tomography Tracers.Acoustic structure quantification (ASQ): a new tool in sonographic examination of liver lesions in hepatic alveolar echinococcosis.In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae.Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.Chemotherapy in alveolar echinococcosis of multi-organs: what's the role?Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?Alveolar echinococcosis in Germany, 1992-2016. An update based on the newly established national AE database.Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients.Current interventional strategy for the treatment of hepatic alveolar echinococcosis.Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity.Stereological evaluation of treatment response in patients with non-resectable hepatic alveolar echinococcosis using computed tomography via the Cavalieri method.An unusual presentation of alveolar echinococcosis in a 12-yr-old immunocompetent child.
P2860
Q24674880-76CAED19-2FF6-458D-ADE3-E5FEEC96D49AQ26851691-95B1C2E8-29AB-43A3-A90F-1A314C2F4AEAQ28601626-197262E6-F152-4042-9D19-DF71542E7A76Q30383465-0A75AFE9-2327-4FE8-B287-4483F63AE3EBQ30398178-F125BF46-9E3D-4865-8CD3-E22A9AA79074Q34741945-E60711FD-1298-4849-A7CC-8CAFE6C3CB84Q35532151-144F9DB5-A90A-4D02-976E-F2BC936EAF8FQ35781785-75163D55-F1BC-4032-B87B-4453C902AC3DQ36422498-17975A87-3D10-4CE7-98EA-BDD5B8B9C354Q36870795-D5AA1CF0-6219-40CF-A584-ABF05B5885F7Q36882080-0305399A-B6F8-49B2-9008-83AB2B26F5E0Q37417747-A479CD87-0BF9-44A8-84C8-BA6C8E2FC933Q37599990-26F219E3-89E3-4577-BF49-993687A14747Q37896156-7A17098D-08A8-4BFE-889A-0A6809F8C859Q38078942-38981106-4D50-4F8E-B15A-4130DA08682EQ38620298-C8A9A8E2-70FE-4514-87FC-594DD33712E6Q38984816-63B95FFA-F201-4CEE-B925-C768C530FB6FQ40932389-2DCE9D9D-070F-4A06-A873-410C01F8CAACQ41622117-314640CC-D849-4B6B-9199-102D483CFF39Q41722968-A0B28957-5C2A-4213-986E-AA43DEC748B7Q43152059-4F2AAFFE-ADDB-4685-81DF-19E08EB370AEQ45193310-C467DB1F-D4D8-4E25-A317-829BDA148854Q45230895-E0DFF8A4-2DD3-464E-87C2-5BB2C0E5C42CQ46103428-6958880E-CC53-45F8-A40F-C0696A21B4C5Q48091221-00253CD2-3B33-43D3-8257-BF528DFDEEB8Q48144039-E73227BA-5D4B-4211-AA9F-F048CDF4D66FQ49021044-F1AA4714-4A61-4317-BEC1-174EEB3FC613Q53061613-A8340FFE-5B97-480E-AE9D-0C836B117B69Q53512385-226E9BA8-3AA1-45A1-ABD1-FBBD4F2BD6AEQ54430475-8F6E8195-2569-4CC2-9800-944629A6F45C
P2860
Structured treatment interruption in patients with alveolar echinococcosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Structured treatment interruption in patients with alveolar echinococcosis.
@en
Structured treatment interruption in patients with alveolar echinococcosis.
@nl
type
label
Structured treatment interruption in patients with alveolar echinococcosis.
@en
Structured treatment interruption in patients with alveolar echinococcosis.
@nl
prefLabel
Structured treatment interruption in patients with alveolar echinococcosis.
@en
Structured treatment interruption in patients with alveolar echinococcosis.
@nl
P2093
P356
P1433
P1476
Structured treatment interruption in patients with alveolar echinococcosis.
@en
P2093
Burkhard Manfras
Hanns Martin Seitz
Kassa Darge
Peter Kern
Stefan Reuter
Sven Norbert Reske
Wolfgang Kratzer
P304
P356
10.1002/HEP.20078
P407
P577
2004-02-01T00:00:00Z